Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

COMPASS Pathways plc Regulatory Filings 2021

Apr 27, 2021

32720_rns_2021-04-27_8ea11c24-8aa6-40e4-8425-bd5a56ce1bfb.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

CORRESP 1 filename1.htm html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd" Document created using Wdesk Copyright 2021 Workiva Document

VIA EDGAR

April 27, 2021

Office of Life Sciences

Division of Corporation Finance

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Attention: Mr. Timothy Buchmiller

Re:
Requested Date: April 29, 2021
Requested Time: 4:00 p.m., Eastern Time

Dear Mr. Buchmiller:

Pursuant to Rule 461 under the Securities Act of 1933, as amended (the “ Act ”), COMPASS Pathways plc (the “ Company ”) hereby requests that the effective date of the above-referenced registration statement (the “ Registration Statement ”) be accelerated to April 29, 2021, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP, request by telephone that such Registration Statement be declared effective at some other time. In making this acceleration request, the Company acknowledges that it is aware of its responsibilities under the Act.

Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin Procter LLP, by calling Benjamin K. Marsh at (212) 813-8816. We also respectfully request that a copy of the written order from the Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin Procter LLP, Attention: Benjamin K. Marsh, [email protected].

[Signature page follows]

April 27, 2021

Page 2

Sincerely,
COMPASS Pathways plc
/s/ George Goldsmith
George Goldsmith
Chief Executive Officer
cc:
Benjamin K. Marsh, Esq., Goodwin Procter LLP